Highlights • Novel technologies present novel opportunities in patient care that should be welcomed. • However, studies suggest their reception ranges from the enthusiastic to the reluctant across Europe. • Key to integrating advances into health care depends on keeping patient interests at the forefront. • Major strategic EU reviews over 2024-2025 will impact on health and public spending—positively or negatively. • Focus on equitable access, infrastructure, and governance to deliver tech advancements to patients effectively.
All Keywords
【저자키워드】 Health care, Personalized medicine, Next-generation sequencing, public health genomics,
【저자키워드】 Health care, Personalized medicine, Next-generation sequencing, public health genomics,